Skip to Content

WPI 844 (Glipizide Extended Release 5 mg)

Pill with imprint WPI 844 is Orange, Round and has been identified as Glipizide Extended Release 5 mg. It is supplied by Watson Laboratories, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 844

Glipizide extended release 5 mg WPI 844
Glipizide extended release 5 mg WPI 844  Front
Glipizide extended release 5 mg WPI 844  Back
Glipizide extended release 5 mg WPI 844

Glipizide Extended Release

Imprint:
WPI 844
Strength:
5 mg
Color:
Orange
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00591-0844 Watson Pharmaceuticals, Inc.
68084-0111 Amerisource Health Services
10370-0190 Anchen Pharmaceuticals, Inc.
54569-5547 A-S Medication Solutions, LLC (repackager)
54868-5210 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide